Vor Biopharma Stock Target Price and Analyst Consensus

VOR Stock  USD 1.01  0.03  2.88%   
The current analyst and expert consensus on Vor Biopharma is Strong Buy, with 6 strong buy opinions. The current projected Vor Biopharma target price consensus is 15.44 with 8 analyst opinions. Check out Macroaxis Advice on Vor Biopharma to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
To learn how to invest in Vor Stock, please use our How to Invest in Vor Biopharma guide.
The most common way Vor Biopharma analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Vor Biopharma executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Vor Biopharma. We strongly encourage you to use your own analysis of Vor Biopharma to validate this buy or sell advice. Vor Biopharma buy-or-sell recommendation module provides average expert sentiment on the projected Vor Biopharma target price to derive its highest and lowest estimates based on projected price volatility of 5.6893.
Lowest Forecast
14.05
Highest Forecast
17.14
Target Price
15.44
As of 12/11/2024, Gross Profit is likely to drop to about (3.7 M). At this time, Vor Biopharma's Net Tangible Assets are relatively stable compared to the past year. As of 12/11/2024, Net Debt is likely to grow to about 4.5 M, while Short and Long Term Debt Total is likely to drop slightly above 25.4 M.
  
It's important to approach Vor Biopharma's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Vor Biopharma price targets

Vor Biopharma's stock target price is an estimate of its future price, usually made by analysts. Using Vor Biopharma's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Vor Biopharma's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Vor Biopharma's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Vor Biopharma Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Vor Biopharma is a key component of Vor Biopharma valuation and have some predictive power on the future returns of a Vor Biopharma.
Hype
Prediction
LowEstimatedHigh
0.051.016.70
Details
Intrinsic
Valuation
LowRealHigh
0.234.5610.25
Details
Naive
Forecast
LowNextHigh
0.021.136.82
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.42-0.38-0.33
Details

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Momentum Idea
Momentum
Invested over 40 shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 50 shares
Driverless Cars Idea
Driverless Cars
Invested over 200 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 40 shares
Investor Favorites Idea
Investor Favorites
Invested few shares
Impulse Idea
Impulse
Invested few shares
Investing Idea
Investing
Invested few shares
Technology Idea
Technology
Invested few shares
Millennials Best Idea
Millennials Best
Invested few shares

Additional Tools for Vor Stock Analysis

When running Vor Biopharma's price analysis, check to measure Vor Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vor Biopharma is operating at the current time. Most of Vor Biopharma's value examination focuses on studying past and present price action to predict the probability of Vor Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vor Biopharma's price. Additionally, you may evaluate how the addition of Vor Biopharma to your portfolios can decrease your overall portfolio volatility.